Ebola explained: Symptoms, treatment and vaccines
Ebola is rare, deadly and has multiple variations. There is a vaccine for the Zaire type, now trials for another are underway ...
EUR/GBP Price Forecast: Gains ahead of BoE’s policy decision
The EUR/GBP pair rises to near 0.8333 in Thursday’s European session. The cross gains as the Pound Sterling (GBP) weakens ...
TMCnet5h
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc ("GSK" or "the Company") (NYSE: GSK) for violations of §§10 (b) and 20 ...
GBP/JPY Price Forecast: Bearish outlook remains intact below 190.50
The Japanese Yen (JPY) is one of the world’s most traded currencies. Its value is broadly determined by the performance of the Japanese economy, but more specifically by the Bank of Japan’s policy, ...
Le Lézard7h
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of American Depositary Receipts ("ADRs") of GSK plc between February 5, ...
centerforbiosimilars5h
CHMP Pushes 3 Biosimilars Forward, Spelling Hope for Ophthalmology, Supportive Care Markets
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended 3 biosimilars and new indications for reference biologics, moving them closer to final European ...
Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.
Shanghai Henlius Biotech, Inc. (2696.HK) today announced it has entered into a license agreement with Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd., (BSE: ...